Eyevensys Closes $30M Series B Financing

PARIS & FORT WORTH, Texas--(BUSINESS WIRE)-- #Finance--Eyevensys developing non-viral gene therapies for retinal and other ophthalmic diseases, announces that it has completed a $30M Series B financing.

Full Story →